Htl-Strefa, Inc. Htl-Strefa Barrier Bandage

BANDAGE BARRIER INJECTSAFE 100/BX 20BX/CS
Key Features
  • SKU: HTL-3070
  • Condition: Factory New
  • Country of Origin: China
  • Weight: 7.7 lb

  • Learn more:

Contact The Manufacturer
  • MFR: HTL-STREFA, Inc. Ships from MFI Medical
  • MPN: 3070
  • Phone: (770) 528-0410
$604.33

+Free Shipping*

Special Order Item

Est. Delivery:
%3Cp%3EEarn%20[points_amount]%20when%20you%20buy%20this%20item.%3C/p%3E

Shop with Confidence

Free Shipping

+

Free Returns

Payment Options

+

Price Match Guarantee

Sales Tax Exemption

+

Dedicated Account Managers

Description

HTL-STREFA, Inc. . Patented pre-injection self-adhesive bandage applied prior to subcutaneous or intramuscular injection, providing containment of post-injection bleeding to limit healthcare professional contact to bloodborne pathogens. Allows healthcare professional to use both hands to dispose of the needle and syringe.

Frequently asked questions

What is the primary function of this barrier bandage?

The HTL-STREFA Barrier Bandage is designed to be applied before an injection to effectively contain any post-injection bleeding. This critical feature helps to reduce the risk of healthcare professionals being exposed to bloodborne pathogens and facilitates the safe, two-handed disposal of needles and syringes.

How does the barrier bandage enhance safety?

The HTL-STREFA Barrier Bandage is a patented, self-adhesive bandage applied pre-injection to effectively contain post-injection bleeding. This design significantly reduces the risk of healthcare professionals’ exposure to bloodborne pathogens and allows for two-handed, safe disposal of needles and syringes, enhancing overall safety and efficiency in clinical settings.

How does this bandage help reduce the risk of exposure to bloodborne pathogens?

The HTL-STREFA Barrier Bandage helps reduce exposure to bloodborne pathogens by containing post-injection bleeding. This creates a safer environment for healthcare professionals.

Does this bandage facilitate safer needle disposal?

Yes, by containing the blood, the bandage allows healthcare professionals to use both hands for safer needle and syringe disposal, minimizing the risk of accidental needle sticks and contamination.

Who is the target user for the HTL-STREFA Barrier Bandage?

The HTL-STREFA Barrier Bandage is primarily intended for use by healthcare professionals in clinical settings where subcutaneous or intramuscular injections are administered.

Is the HTL-STREFA Barrier Bandage a new product?

Yes, the Htl-Strefa Barrier Bandage is sold as Factory New stock. This assurance guarantees the highest standard of quality and hygiene for this patented medical accessory.

Does it use patented technology?

Yes, the HTL-STREFA Barrier Bandage uses patented technology to ensure its effectiveness and reliability in containing post-injection bleeding.

When should the bandage be applied?

The HTL-STREFA Barrier Bandage is designed for application prior to subcutaneous or intramuscular injections to help contain post-injection bleeding.

Is the bandage self-adhesive?

Yes, the HTL-STREFA Barrier Bandage is self-adhesive, making it easy to apply and ensuring a secure fit during use.

Does it offer superior pathogen protection?

Yes, the HTL-STREFA Barrier Bandage is specifically designed to enhance safety by containing post-injection bleeding. This innovative feature significantly reduces the risk of healthcare professionals being exposed to bloodborne pathogens and allows for safe, two-handed disposal of needles and syringes.